Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2025-08-10 Remuneration Information
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
董事、高管薪酬管理制度
Remuneration Information Classification · 95% confidence The document is a detailed announcement of the company's board and senior management remuneration management system, including principles, salary standards, payment methods, and adjustment criteria. It is issued by the company's board and mentions approval by the board and submission to the shareholders' meeting. The content focuses on governance and compensation policies for directors and senior executives, without financial statements or earnings data. It is not a full annual report, earnings release, or audit report. It is not a proxy solicitation or voting result announcement. The document fits the category of Remuneration Information, which covers reports detailing compensation for top executives and directors.
2025-08-10 Chinese
承诺管理制度
Regulatory Filings Classification · 95% confidence The document is a formal announcement from Guangdong Driving Force Biotechnology Group Co., Ltd. regarding the company's commitment management system. It details the company's internal policies and procedures related to commitments made by controlling shareholders, actual controllers, related parties, and others. The document includes references to legal and regulatory frameworks, internal governance, and disclosure obligations. It is not a financial report, earnings release, or a presentation. It is also not a notice of voting results, director dealings, or capital changes. The document is a regulatory announcement about governance and compliance policies, which does not fit into more specific categories like Annual Report, Interim Report, or Management Reports. Given its nature as a formal regulatory disclosure about company policies and compliance, the best fitting category is Regulatory Filings (RNS). The document length is under 5,000 characters and contains substantive policy content, not just a report publication announcement. Therefore, the classification is RNS with high confidence.
2025-08-10 Chinese
对外投资管理制度
Board/Management Information Classification · 95% confidence The document is titled as an investment management system of Guangdong Driving Force Biotechnology Group Co., Ltd. It details the company's internal policies and procedures for external investments, including decision-making processes, approval authorities, risk management, and reporting obligations. The document is a comprehensive internal governance and procedural manual rather than a financial report, announcement, or regulatory filing. It does not contain financial statements, earnings data, voting results, or any form of capital market transaction announcement. It is not a report publication announcement or a certification. The content aligns with internal governance and management information related to investment activities. Therefore, the most appropriate classification is Board/Management Information (MANG), as it relates to management policies and internal control systems regarding investments.
2025-08-10 Chinese
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is a detailed internal governance policy specifically about the working system of the Independent Directors' Special Meeting at Guangdong Driving Force Biotechnology Group Co., Ltd. It includes procedural rules, voting mechanisms, duties, and responsibilities of independent directors. There is no financial data, no mention of financial results, no earnings, no audit opinions, no shareholder voting results, no capital changes, no legal proceedings, and no announcements of report publications. The document is a governance-related internal regulation, focusing on board structure and governance practices. Therefore, it fits best under the category Governance Information (CGR). The document length is 3368 characters, which is not extremely short, and it contains substantive governance content rather than just an announcement or certification. Hence, the classification is CGR with high confidence.
2025-08-10 Chinese
证券事务代表任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a securities affairs representative at Guangdong Driving Force Biotechnology Group Co., Ltd. It details the appointment decision made at a board meeting, the qualifications of the appointed person, and compliance with relevant laws. There is no financial data, no report or presentation content, and no mention of voting results or dividends. This fits the category of Board/Management Information (MANG), as it concerns a change in company personnel related to securities affairs representation.
2025-08-10 Chinese
信息披露管理制度
Governance Information Classification · 95% confidence The document is a detailed disclosure management system of Guangdong Drive Biological Technology Group Co., Ltd., outlining the company's information disclosure obligations, principles, types of reports (annual, interim, quarterly, and temporary reports), procedures for disclosure, responsibilities of directors and management, and regulatory compliance with Chinese securities laws and Beijing Stock Exchange rules. It is a comprehensive governance and procedural document related to information disclosure management rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or specific event announcements but rather the rules and policies governing disclosures. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-10 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.